3386.T)">
Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure from was processed by Pulse News Wire on February 13, 2026. It represents a primary source document for Japanese Governance sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Source disclosure: February 13, 2026 COSMO BIO COMPANY,LIMITED [3386.T] TOKYO, Feb 13 (Pulse News Wire) – Cosmo BIO Company,limited (3386.T) announced significant executive appointments effective April 1, 2026. President and CEO Masahiko Shibayama will retain his role while also taking on additional responsibilities as Executive Director and Chairman. Other key changes include: - Junko Tokushima appointed as Senior Managing Director overseeing Marketing, Product Information, Legal A